News

How new technology can impact cardiac imaging in oncology clinical trials and have broader implications for patient safety.

Social media uses transparency to highlight alleged gaps in clinical trial transparency and offers a more powerful approach to health campaigners.

Click the title above to open the Applied Clinical Trials January/February 2020 issue in an interactive PDF format.

David Arthur, CEO of Salarius, discusses efficacy, collaborating with nonprofit institutes to obtain funding, and garnering patient support to increase recruitment in clinical trials.

ViiV Healthcare outlines techniques and tips for implementing a technology-based process for handling compassionate use requests.

A compilation of recently released news briefs that pertain to the clinical trials industry.

With the biopharma industry making strides in gene therapies by focusing on patients with specific genetic traits, Karmen Trzupek, Director of Clinical Trial Services at InformedDNA, discusses how to address the presented challenges of this approach.

The EMA is going to take a rather bolder approach to the use of data than in Germany, judging from major statements just out at the end of January.

John Rigg, senior principal, Predictive Analytics, Real World Solutions at IQVIA, discusses how patient disease modeling and diagnostic prediction is made possible with artificial intelligence and machine learning.

During clinical trials of pharmaceutical treatments, sponsors and CROs need to detect possible suicidal ideation and behavior related to their drug during baseline assessments, and throughout treatment as well as during the follow up phases.

Non-reporting has attained a high profile in Europe, partly because of the EMA's attempts to tackle the problem, and partly because of a highly-visible “name-and-shame” social media campaign.

While the clinical trials industry has always been a slacker in innovation, we'll soon start seeing automation and artificial intelligence significantly impacting the way biopharmaceutical enterprises run clinical trials, says Moe Alsumidaie.